Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAD-DIAB: Optimizing Glycemic Control During Exercise in Children with T1D
NCT02824510Completed
- Start
- Aug 2014
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of insulin aspart, insulin glargine and insulin detemir in type 1 diabetes mellitus (T1D) (2 arms). Primary endpoint: Subcutaneous glucose evolution. Started Aug 2014; status: completed.
02
Drugs
insulin aspartinsulin glargineinsulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02824510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824510.